Roche Holding AG (LON:0TDF)

London flag London · Delayed Price · Currency is GBP · Price in USD
41.80
-0.29 (-0.70%)
At close: Mar 26, 2025
33.01%
Market Cap 208.46B
Revenue (ttm) 55.00B
Net Income (ttm) 7.30B
Shares Out n/a
EPS (ttm) 9.09
PE Ratio 28.57
Forward PE n/a
Dividend 0.66 (1.55%)
Ex-Dividend Date Mar 28, 2025
Volume 45
Average Volume 42,994
Open 42.66
Previous Close 42.10
Day's Range 42.66 - 42.66
52-Week Range 29.35 - 41.85
Beta n/a
RSI 55.95
Earnings Date Apr 25, 2025

About Roche Holding AG

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It also provides in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and others; diagn... [Read more]

Industry Pharmaceutical Preparations
Founded 1896
Employees 103,249
Stock Exchange London Stock Exchange
Ticker Symbol 0TDF
Full Company Profile

Financial Performance

In 2024, Roche Holding AG's revenue was 62.40 billion, an increase of 3.23% compared to the previous year's 60.44 billion. Earnings were 8.28 billion, a decrease of -28.01%.

Financial numbers in CHF Financial Statements

News

There is no news available yet.